Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
Hamilton region’s life science and health tech community driving economic prosperity HAMILTON, ON – November
Applications are now open for this year’s cohort of innovative startups Hamilton – October 12,
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
[ale_divider style=”thin” text=”notext”] Divider Text [/ale_divider] This article appeared on canhealth.com. To read the original
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
Learn about how FluidAI Medical’s postoperative monitoring solution is leveraging AI to detect anastomotic leaks and improve recovery times.
Learn how Swift Medical is reshaping the way wounds are imaged for diagnosis with AI and data-driven technology.
Discover how Synmedix is combating antibiotic resistance with support from the SOPHIE program and Synapse Life Science Competition.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.
